317 related articles for article (PubMed ID: 28486536)
21. Differential expression analysis of clear cell renal cell carcinomas in The Cancer Genome Atlas distinguishes an aggressive subset enriched with chromosomes 7 and 12 gains.
Pan CC; Yeh YC; Wang YC; Chang YH
Histopathology; 2020 Jun; 76(7):950-958. PubMed ID: 32170764
[TBL] [Abstract][Full Text] [Related]
22. The chromatin remodeling gene ARID1A is a new prognostic marker in clear cell renal cell carcinoma.
Lichner Z; Scorilas A; White NM; Girgis AH; Rotstein L; Wiegand KC; Latif A; Chow C; Huntsman D; Yousef GM
Am J Pathol; 2013 Apr; 182(4):1163-70. PubMed ID: 23416164
[TBL] [Abstract][Full Text] [Related]
23. CLEC3B is downregulated and inhibits proliferation in clear cell renal cell carcinoma.
Liu J; Liu Z; Liu Q; Li L; Fan X; Wen T; An G
Oncol Rep; 2018 Oct; 40(4):2023-2035. PubMed ID: 30066941
[TBL] [Abstract][Full Text] [Related]
24. DNA methylation status defines clinicopathological parameters including survival for patients with clear cell renal cell carcinoma (ccRCC).
Evelönn EA; Degerman S; Köhn L; Landfors M; Ljungberg B; Roos G
Tumour Biol; 2016 Aug; 37(8):10219-28. PubMed ID: 26831665
[TBL] [Abstract][Full Text] [Related]
25. The study on copy number alteration of clear cell renal cancer in Chinese population.
Zhang N; Chen S; Jiang G; Wu Y; Shao J; Liu W; Wang X; Na R; Xu J
J Cancer; 2020; 11(1):16-24. PubMed ID: 31892969
[No Abstract] [Full Text] [Related]
26. Parallel evolution of tumour subclones mimics diversity between tumours.
Martinez P; Birkbak NJ; Gerlinger M; McGranahan N; Burrell RA; Rowan AJ; Joshi T; Fisher R; Larkin J; Szallasi Z; Swanton C
J Pathol; 2013 Aug; 230(4):356-64. PubMed ID: 23716380
[TBL] [Abstract][Full Text] [Related]
27. Survival Prediction of Clear Cell Renal Cell Carcinoma Based on Gene Expression Similarity to the Proximal Tubule of the Nephron.
Büttner F; Winter S; Rausch S; Reustle A; Kruck S; Junker K; Stenzl A; Agaimy A; Hartmann A; Bedke J; Schwab M; Schaeffeler E
Eur Urol; 2015 Dec; 68(6):1016-20. PubMed ID: 26072688
[TBL] [Abstract][Full Text] [Related]
28. CNApp, a tool for the quantification of copy number alterations and integrative analysis revealing clinical implications.
Franch-Expósito S; Bassaganyas L; Vila-Casadesús M; Hernández-Illán E; Esteban-Fabró R; Díaz-Gay M; Lozano JJ; Castells A; Llovet JM; Castellví-Bel S; Camps J
Elife; 2020 Jan; 9():. PubMed ID: 31939734
[TBL] [Abstract][Full Text] [Related]
29. The two glycolytic markers GLUT1 and MCT1 correlate with tumor grade and survival in clear-cell renal cell carcinoma.
Ambrosetti D; Dufies M; Dadone B; Durand M; Borchiellini D; Amiel J; Pouyssegur J; Rioux-Leclercq N; Pages G; Burel-Vandenbos F; Mazure NM
PLoS One; 2018; 13(2):e0193477. PubMed ID: 29481555
[TBL] [Abstract][Full Text] [Related]
30. XRCC3 Thr241Met and XPD Lys751Gln gene polymorphisms and risk of clear cell renal cell carcinoma.
Loghin A; Bănescu C; Nechifor-Boila A; Chibelean C; Orsolya M; Nechifor-Boila A; Tripon F; Voidazan S; Borda A
Cancer Biomark; 2016; 16(2):211-7. PubMed ID: 26682510
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive analysis of a novel lncRNA profile reveals potential prognostic biomarkers in clear cell renal cell carcinoma.
Liu T; Sui J; Zhang Y; Zhang XM; Wu WJ; Yang S; Xu SY; Hong WW; Peng H; Yin LH; Pu YP; Liang GY
Oncol Rep; 2018 Sep; 40(3):1503-1514. PubMed ID: 30015930
[TBL] [Abstract][Full Text] [Related]
32. Putative Drivers of Aggressiveness in TCEB1-mutant Renal Cell Carcinoma: An Emerging Entity with Variable Clinical Course.
DiNatale RG; Gorelick AN; Makarov V; Blum KA; Silagy AW; Freeman B; Chowell D; Marcon J; Mano R; Sanchez A; Attalla K; Weng S; Voss M; Motzer RJ; Russo P; Coleman JA; Reuter VE; Chen YB; Chan TA; Reznik E; Tickoo SK; Hakimi AA
Eur Urol Focus; 2021 Mar; 7(2):381-389. PubMed ID: 31813809
[TBL] [Abstract][Full Text] [Related]
33. Integrated genomic analysis identifies clinically relevant subtypes of renal clear cell carcinoma.
Wu P; Liu JL; Pei SM; Wu CP; Yang K; Wang SP; Wu S
BMC Cancer; 2018 Mar; 18(1):287. PubMed ID: 29534679
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis A virus cellular receptor 1/kidney injury molecule-1 is a susceptibility gene for clear cell renal cell carcinoma and hepatitis A virus cellular receptor/kidney injury molecule-1 ectodomain shedding a predictive biomarker of tumour progression.
Cuadros T; Trilla E; Vilà MR; de Torres I; Vilardell J; Messaoud NB; Salcedo M; Sarró E; López-Hellin J; Blanco A; Mir C; Ramón y Cajal S; Itarte E; Morote J; Meseguer A
Eur J Cancer; 2013 May; 49(8):2034-47. PubMed ID: 23352434
[TBL] [Abstract][Full Text] [Related]
35. Putative biomarker genes for grading clear cell renal cell carcinoma.
Maruschke M; Koczan D; Reuter D; Ziems B; Nizze H; Hakenberg OW; Thiesen HJ
Urol Int; 2011; 87(2):205-17. PubMed ID: 21757870
[TBL] [Abstract][Full Text] [Related]
36. Expression of pre-selected TMEMs with predicted ER localization as potential classifiers of ccRCC tumors.
Wrzesiński T; Szelag M; Cieślikowski WA; Ida A; Giles R; Zodro E; Szumska J; Poźniak J; Kwias Z; Bluyssen HA; Wesoly J
BMC Cancer; 2015 Jul; 15():518. PubMed ID: 26169495
[TBL] [Abstract][Full Text] [Related]
37. Genetic alteration in notch pathway is associated with better prognosis in renal cell carcinoma.
Feng C; Xiong Z; Jiang H; Ding Q; Fang Z; Hui W
Biofactors; 2016; 42(1):41-8. PubMed ID: 26662507
[TBL] [Abstract][Full Text] [Related]
38. Identification of genomic alterations associated with metastasis and cancer specific survival in clear cell renal cell carcinoma.
Sanjmyatav J; Junker K; Matthes S; Muehr M; Sava D; Sternal M; Wessendorf S; Kreuz M; Gajda M; Wunderlich H; Schwaenen C
J Urol; 2011 Nov; 186(5):2078-83. PubMed ID: 21944119
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive analysis of copy number aberrations in microsatellite stable colon cancer in view of stromal component.
Alonso MH; Aussó S; Lopez-Doriga A; Cordero D; Guinó E; Solé X; Barenys M; de Oca J; Capella G; Salazar R; Sanz-Pamplona R; Moreno V
Br J Cancer; 2017 Jul; 117(3):421-431. PubMed ID: 28683472
[TBL] [Abstract][Full Text] [Related]
40. Copy Number Alterations in Hepatoblastoma: Literature Review and a Brazilian Cohort Analysis Highlight New Biological Pathways.
Barros JS; Aguiar TFM; Costa SS; Rivas MP; Cypriano M; Toledo SRC; Novak EM; Odone V; Cristofani LM; Carraro DM; Werneck da Cunha I; Costa CML; Vianna-Morgante AM; Rosenberg C; Krepischi ACV
Front Oncol; 2021; 11():741526. PubMed ID: 34956867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]